IVERIC bio, Inc. Proceeds from Stock Options Exercised
IVERIC bio, Inc. reported Proceeds from Stock Options Exercised of $7.94 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-03-01
- IVERIC bio, Inc. proceeds from stock options exercised for the quarter ending 2018-12-31 was $0.00.
- IVERIC bio, Inc. proceeds from stock options exercised for the quarter ending 2018-09-30 was $0.00.
- IVERIC bio, Inc. proceeds from stock options exercised for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- IVERIC bio, Inc. proceeds from stock options exercised for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- IVERIC bio, Inc. proceeds from stock options exercised for fiscal 2022 was $7.94M, a 339.33% increase from fiscal 2021.
- IVERIC bio, Inc. proceeds from stock options exercised for fiscal 2021 was $1.81M, a 475.80% increase from fiscal 2020.
- IVERIC bio, Inc. proceeds from stock options exercised for fiscal 2020 was $314.00K, a 63.54% increase from fiscal 2019.
- IVERIC bio, Inc. proceeds from stock options exercised for fiscal 2019 was $192.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2022-12-31 | $7.94M 10-K · filed 2023-03-01 | |||
| 2021-12-31 | $1.81M 10-K · filed 2023-03-01 | |||
| 2020-12-31 | $314.00K 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $192.00K 10-K · filed 2022-02-24 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $0.00 derived: sum of 2 quarters · filed 2021-03-04 | $0.00 derived: sum of 3 quarters · filed 2021-03-04 | $0.00 10-K · filed 2021-03-04 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-02 | $0.00 derived: sum of 2 quarters · filed 2018-11-02 | $0.00 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-01 | $0.00 10-Q · filed 2018-08-01 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $15.00K derived: sum of 3 quarters · filed 2020-02-27 | $33.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-02 | $15.00K derived: sum of 2 quarters · filed 2018-11-02 | $33.00K 10-Q · filed 2018-11-02 | $1.58M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $15.00K 10-Q · filed 2018-08-01 | $46.00K 10-Q · filed 2018-08-01 | $1.58M derived: sum of 3 quarters · filed 2019-02-28 | $3.17M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $31.00K 10-Q · filed 2018-05-09 | $1.57M derived: sum of 2 quarters · filed 2019-02-28 | $3.16M derived: sum of 3 quarters · filed 2019-02-28 | $6.20M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $3.13M derived: sum of 2 quarters · filed 2019-02-28 | $6.17M derived: sum of 3 quarters · filed 2019-02-28 | $6.93M 10-K · filed 2019-02-28 |
| 2016-09-30 | $1.59M 10-Q · filed 2017-11-08 | $4.63M derived: sum of 2 quarters · filed 2017-11-08 | $5.40M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $3.04M 10-Q · filed 2017-08-02 | $3.81M 10-Q · filed 2017-08-02 | ||
| 2015-12-31 | $11.47M 10-K · filed 2018-03-05 |